Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAMPT | P43490 | 4/20 | 0.56 |
| ▸ | SCD | O00767 | 16/20 | 0.52 |
| ▸ | SCD5 | Q86SK9 | 12/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3615748 | 0.91 | SCD (0.53) | NAMPTSCDSCD5 | |
| SCHEMBL3598199 | 0.91 | NAMPT (0.56) | NAMPTSCDSCD5 | |
| SCHEMBL3603799 | 0.91 | SCD5 (0.51) | NAMPTSCDSCD5 | |
| SCHEMBL3605404 | 0.91 | NAMPT (0.63) | NAMPTSCDSCD5 | |
| SCHEMBL3602755 | 0.90 | SCD (0.51) | NAMPTSCDSCD5 | |
| SCHEMBL3616386 | 0.89 | ITK (0.51) | NAMPTSCDSCD5 | |
| SCHEMBL3599020 | 0.87 | SMN1; SMN2 (0.57) | NAMPTSCDSCD5 | |
| SCHEMBL3603596 | 0.87 | SCD (0.53) | NAMPTSCDSCD5 | |
| SCHEMBL3600477 | 0.87 | NAMPT (0.51) | NAMPTSCDSCD5 | |
| SCHEMBL3596504 | 0.87 | SMN1; SMN2 (0.57) | NAMPTSCDSCD5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100041696-A1 | Compounds | SMITHKLINE BEECHAM CORPORATION | 2010-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041696-A1 | Compounds | CYP11B2, SCD, CYP3A5 | NAMPT 869/4885SCD 2/4885SCD5 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.